Layn Natural Ingredients to invest in infrastructure expansion and innovation

Layn plans investment in infrastructure and innovation.

Layn Natural Ingredients, one of the world’s largest innovators of natural botanical extract ingredients and solutions serving the biggest brands in food, beverage, flavor, nutraceutical, personal care, animals and pets, is securing a targeted $148 million USD from stock to be invested in infrastructure expansion and innovation to solidify its global leadership position and further its innovation, R&D and globally secure supply chain.


Layn’s next generation manufacturing facility is expected to be completed in three years, with designed capacity to process an additional 4000mt of stevia leaf extract per year. Consumers worldwide are increasingly demanding more natural ingredients over synthetics, and the strategically planned expansion will meet the growing global demand of natural sweeteners and polyphenol-rich botanical ingredients. Layn will also expand its sustainable agronomy innovation programs to expand its transparent and traceable supply chain.


While the industry experienced unprecedented supply chain disruptions due to surging demand for natural immune support, stress management and other natural, healthy ingredients in 2020, Layn Natural Ingredients continued to provide a reliable and secure supply. Layn maintained reliable inventory despite industry fluctuations - and even explicitly guarantees long-term supply for annual contracts.


Layn is the largest direct-manufacturer of stevia and monk fruit natural sweetener extracts in the world, and directly produces and innovates a variety of additional functional botanical extracts including polyphenol-rich botanical extracts such as pomegranate, rosemary, and sophora japonica; tea extracts including green tea, black tea, oolong and pu’er. Following its 2020 acquisition of Wagott, Layn is now the largest manufacturer of green tea extracts in China.


Layn has achieved over 50 patents globally in science and innovation, and the new funding will also support Layn’s ongoing commitment to the discovery of new botanical extract innovations and science for specific botanical compounds. This includes investment in Layn’s globally-connected, state-of-the-art innovation centers – located in Asia, Europe and the US. These centers bring together leading industry scientists and experts to conduct ongoing research and provide formulation and lab support to manufacturing partners around the world.



Page 1 of 243
Next Page